Five things for pharma marketers to know: Wednesday, November 29, 2023

Five things for pharma marketers to know:

• The Food and Drug Administration announced it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

• The Biden administration urged drugmakers like Sanofi and AstraZeneca to ramp up manufacturing of RSV vaccines to meet demand for the winter season.

• Oncology company Novocure said it is laying off 13% of its staff, or around 200 employees, as it cuts $60 million in operating expenses.

• Novavax’s protein-based COVID-19 vaccine has been granted emergency-use listing by the World Health Organization.

• An opinion piece argued that drugmakers need to be more open about a dangerous Alzheimer’s drug side effect.